المؤلفون: Rouce RH; Rayne H. Rouce is an associate professor at the Center for Cell and Gene Therapy, Dan L. Duncan Comprehensive Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Porteus MH; Matthew H. Porteus is a professor in the Department of Pediatrics and the Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA, USA.

المصدر: Science (New York, N.Y.) [Science] 2024 Aug 02; Vol. 385 (6708), pp. 475. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Editorial; Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

مواضيع طبية MeSH: Cell- and Tissue-Based Therapy*/economics , Genetic Therapy*/economics , Health Services Accessibility*, Humans ; Anemia, Sickle Cell/therapy ; Anemia, Sickle Cell/genetics ; Neoplasms/therapy ; Neoplasms/genetics ; Cost-Benefit Analysis

المؤلفون: Gardner RA; St Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: rebecca.gardner@stjude.org., White C; Division of Oncology, Cell Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Elsallab M; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Cellular Immunotherapy Program, Mass General Cancer Center, Boston, Massachusetts., Farnia S; Nimitt Consulting, Madison, Wisconsin., Fraint E; Nemours Children's Hospital, Wilmington, Delaware., Grilley B; Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Bateman-House A; Division of Medical Ethics, Department of Population Health, NYU Grossman School of Medicine, New York, New York., Grupp SA; Division of Oncology, Cell Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Kenderian S; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Oluwole OO; Vanderbilt University Medical Center, Nashville, Tennessee., Rouce RH; Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas; Texas Children's Hospital and Texas Children's Cancer Center, Houston, Texas., Spiegel J; Sylvester Comprehensive Cancer Center, Miami, Florida., Shah NN; Pediatric Oncology Branch, Center for Cancer Research, NCI., Sharma A; St Jude Children's Research Hospital, Memphis, Tennessee., Komanduri K; UCSF Health Division of Hematology/Oncology and Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Gill S; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug; Vol. 30 (8), pp. 776-787. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/economics , Immunotherapy, Adoptive*/legislation & jurisprudence , Immunotherapy, Adoptive*/methods, Humans ; Cell- and Tissue-Based Therapy/methods ; Cell- and Tissue-Based Therapy/ethics ; United States ; Health Services Accessibility ; Receptors, Chimeric Antigen ; United States Food and Drug Administration

المؤلفون: Ma R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Woods M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Burkhardt P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Crooks N; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., van Leeuwen DG; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Shmidt D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Couturier J; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Chaumette A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Popat D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Thakkar S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Orozco AF; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Carisey AF; William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, TX 77030, USA., Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: mamonkin@bcm.edu.

المصدر: Cell reports. Medicine [Cell Rep Med] 2024 Jul 16; Vol. 5 (7), pp. 101628. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: CD5 Antigens*/metabolism , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology, Humans ; Cytotoxicity, Immunologic ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Immunotherapy, Adoptive/methods ; Animals ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Antigen, T-Cell/immunology

المؤلفون: Lamble AJ; Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, WA., Schultz LM; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA., Nguyen K; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA., Hsieh EM; Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA., McNerney K; Division of Hematology, Oncology, and Stem Cell Transplantation, Lurie Children's Hospital, Chicago, IL., Rouce RH; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston, TX., Gardner RA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Ghorashian S; Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom., Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Maude SL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3544-3548.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods, Humans ; Adolescent ; Child ; Young Adult ; Receptors, Chimeric Antigen/immunology ; Adult ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Male ; Female

المؤلفون: Miller A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA., Daum R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dell Medical School, University of Texas at Austin, Austin, TX, USA., Wang T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Wu M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Tat C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Pfeiffer T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA; Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, USA., Navai S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Heczey A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Hegde M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Ahmed N; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA., Whittle SB; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Hill L; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Krance R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Omer B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Shekar M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA. Electronic address: Meghan.shekar@bcm.edu.

المصدر: Cytotherapy [Cytotherapy] 2024 May 08. Date of Electronic Publication: 2024 May 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

المؤلفون: Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Wu MJ; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Biostatistics Shared Resource, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Wang T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Biostatistics Shared Resource, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Ma R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Zhang H; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Mehta B; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Lapteva N; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Mei Z; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Smith TS; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Yang L; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Srinivasan M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Burkhardt PM; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Arredondo M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Grilley B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.

المصدر: Blood [Blood] 2024 Mar 28; Vol. 143 (13), pp. 1231-1241.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods , Lymphoma, T-Cell*/drug therapy, Humans ; Neoplasm Recurrence, Local/drug therapy ; T-Lymphocytes ; Chronic Disease ; Antigens, CD19

المؤلفون: Eylon M; College of Medicine, Central Michigan University, Mount Pleasant, MI, United States., Prabhu S; Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA, United States., John S; Department of Pediatrics, The University of Texas Southwestern Medical Center/Children's Health, Dallas, TX, United States., King MJM; College of Medicine, Central Michigan University, Mount Pleasant, MI, United States., Bhatt D; Department for Biology, Stanford University, Palo Alto, CA, United States., Curran KJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Erickson C; Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA, United States., Karras NA; Department of Pediatrics, City of Hope National Medical Center, Duarte, CA, United States., Phillips CL; Department of Pediatrics, University of Cincinnati, Cincinnati, OH, United States.; Cincinnati Children's Hospital Medical Center, Cancer and Blood Disease Institute, Cincinnati, OH, United States., Satwani P; Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Columbia University Medical Center, New York, NY, United States., Hermiston M; University of California, San Francisco Benioff Children's Hospital, San Francisco, CA, United States., Southworth E; University of California, San Francisco Benioff Children's Hospital, San Francisco, CA, United States., Baumeister SHC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana Farber/Boston Children's Hospital, Boston, MA, United States., Talano JA; Department of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, United States., MacMillan ML; Department of Pediatrics, Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, MN, United States., Rossoff J; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States., Bonifant CL; Sidney Kimmel Comprehensive Cancer Center, Division of Pediatric Oncology, Philadelphia, MD, United States., Myers GD; Children's Mercy Hospital, University of Missouri, Columbia, MO, United States., Rouce RH; Bone Marrow Transplant/Stem Cell Transplant Program, Texas Children's Cancer Center, Houston, TX, United States., Toner K; Division of Blood and Marrow Transplant and CAR-T Program, Children's National Hospital, Northwest, DC, United States., Driscoll TA; Pediatric Transplant and Cellular Therapy, Duke Children's Hospital & Health Center, Durham, NC, United States., Katsanis E; Department of Pediatrics, University of Arizona, AZ, United States., Salzberg DB; Center for Cancer and Blood Disorder, Phoenix Children's Hospital, Phoenix, AZ, United States., Schiff D; Division of Hematology/Oncology, Rady Children's Hospital, San Diego, CA, United States., De Oliveira SN; Department of Pediatrics, University of California Los Angeles (UCLA) Mattel Children's Hospital, Los Angeles, CA, United States., Capitini CM; Department of Pediatrics and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States., Pacenta HL; Cook Children's Hematology and Oncology, Cook Children's Hospital, Fort Worth, TX, United States.; Department of Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States., Pfeiffer T; Saint Louis Children's Hospital One Children's Pl, Saint Louis, MO, United States., Shah NC; Yale Medicine, Yale University and Yale New Haven Children's Hospital New Haven, New Haven, CT, United States., Huynh V; Pediatric Oncology, CHOC Children's Hospital of Orange County, Orange County, CA, United States., Skiles JL; Riley Children Health, Indiana University Health, IN, United States., Fraint E; Division of Pediatric Hematology, Oncology, and Cellular Therapy, The Children's Hospital at Montefiore, Bronx, NY, United States., McNerney KO; Department of Pediatrics, John Hopkins All Children's Hospital, St. Petersburg, FL, United States., Quigg TC; Section of Pediatric BMT and Cellular Therapy, Helen DeVos Children's Hospital, Grand Rapids, MI, United States., Krueger J; Division of Hematology/Oncology, The Hospital For Sick Children, Toronto, ON, Canada., Ligon JA; Health Pediatric Blood & Marrow Transplant and Cellular Therapy, University of Florida, Gainesville, FL, United States., Fabrizio VA; Colorado Children's Hospital, University of Colorado, Boulder, CO, United States., Baggott C; Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA, United States., Laetsch TW; Department of Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States., Schultz LM; Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Oct 27; Vol. 14, pp. 1239132. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive* , T-Lymphocytes*, Humans ; Child ; Retrospective Studies ; Infusions, Intravenous ; Administration, Intravenous

المؤلفون: Scherer LD; Texas Children's Cancer Center, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, USA., Rouce RH; Texas Children's Cancer Center, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, USA. Electronic address: rouce@bcm.edu.

المصدر: Best practice & research. Clinical haematology [Best Pract Res Clin Haematol] 2023 Sep; Vol. 36 (3), pp. 101481. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120659 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1924 (Electronic) Linking ISSN: 15216926 NLM ISO Abbreviation: Best Pract Res Clin Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia*/therapy , Hematologic Neoplasms* , Hematopoietic Stem Cell Transplantation*, Humans ; Immunotherapy ; Cell- and Tissue-Based Therapy

المؤلفون: Ramos CA; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Quach DH; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Lulla PD; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Rouce RH; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Sharma S; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Ganesh HR; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Nouraee N; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Briones YD; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Becerra-Dominguez L; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Thakkar SG; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Mehta B; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Perconti S; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Hsieh EM; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Zhang H; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Grilley BJ; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Lapteva N; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Brenner MK; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Heslop HE; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA., Rooney CM; Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Center for Cell and Gene Therapy, Houston, Texas, USA.

المصدر: Hematological oncology [Hematol Oncol] 2023 Jun; Vol. 41 Suppl 2, pp. 83-85.

نوع المنشور: Congress; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/therapy, Humans ; Switzerland ; Congresses as Topic

المؤلفون: Read JA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, Texas; Department of Pediatrics, Division of Hematology and Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, Texas; Department of Pediatrics, Division of Hematology and Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Mo F; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, Texas; Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas., Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, Texas; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas., King KY; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, Texas; Department of Pediatrics, Division of Infectious Disease, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. Electronic address: kyk@bcm.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Mar; Vol. 29 (3), pp. 165.e1-165.e7. Date of Electronic Publication: 2022 Dec 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Bone Marrow Diseases*/metabolism , Bone Marrow Diseases*/pathology , Neoplasms* , Receptors, Chimeric Antigen* , Immunotherapy, Adoptive*/adverse effects, Animals ; Humans ; Mice ; Apoptosis ; Bone Marrow/pathology ; Cytokines/metabolism ; Hematopoietic Stem Cells ; Interleukin-6/metabolism ; Mice, SCID